购物车
- 全部删除
- 您的购物车当前为空
LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist.
LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥ 10,317 | 期货 | |
25 mg | ¥ 22,017 | 期货 | |
50 mg | ¥ 34,617 | 期货 | |
100 mg | ¥ 52,617 | 期货 |
产品描述 | LY2140023 has the potential for schizophrenia.LY2140023 is an orally active prodrug of LY404039. LY404039 is a selective metabotropic glutamate 2/3 receptor agonist. |
体内活性 | LY2140023 (orally;?3, 10, and 300 mg/kg;?once daily for 7 days) dose-dependent increases the levels of the dopamine metabolites dihydroxyphenylacetic acid and homovanillic acid (HVA)[1]. |
别名 | LY2140023 |
分子量 | 366.41 |
分子式 | C12H18N2O7S2 |
CAS No. | 635318-55-7 |
密度 | 1.31g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容